The Clinical Importance of Acquired Abnormalities of Platelet Function
- 3 January 1991
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (1) , 27-39
- https://doi.org/10.1056/nejm199101033240106
Abstract
ACQUIRED abnormalities of platelet function are very common. Platelet function, as assessed by in vitro studies or the bleeding-time test, is affected by a vast number of drugs, common foods, vitamins, and spices; by systemic conditions such as chronic renal disease and surgery requiring cardiopulmonary bypass; and by hematologic disorders such as myeloproliferative and lymphoproliferative diseases, dysproteinemias, and the presence of antiplatelet antibodies. The possibility that these abnormalities may underlie an increased risk of bleeding is an important issue when bleeding occurs without a clear cause or when invasive procedures are required. However, the clinical importance of platelet dysfunction is . . .Keywords
This publication has 187 references indexed in Scilit:
- A Trial of Desmopressin (1-Desamino-8-D-Arginine Vasopressin) to Reduce Blood Loss in Uncomplicated Cardiac SurgeryNew England Journal of Medicine, 1989
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Hyponatremia and seizures after intravenous administration of desmopressin acetate for surgical hemostasisThe Journal of Pediatrics, 1989
- DipyridamoleNew England Journal of Medicine, 1987
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- Molecular Defects in Interactions of Platelets with the Vessel WallNew England Journal of Medicine, 1984
- Effects of Acetylsalicylic Acid Ingestion on Maternal and Neonatal HemostasisNew England Journal of Medicine, 1982
- Ethanol Potentiation of Aspirin-Induced Prolongation of the Bleeding TimeNew England Journal of Medicine, 1982
- Szechwan PurpuraNew England Journal of Medicine, 1980
- Aspirin Prophylaxis of Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1977